The FDA-approved drug Alectinib compromises SARS-CoV-2 nucleocapsid phosphorylation and inhibits viral infection in vitro
Tomer M. Yaron(Memorial Sloan Kettering Cancer Center), Nicholas S. Heaton(Duke University)
Cited by 63
Related Papers
TMEM41B is a host factor required for the replication of diverse coronaviruses including SARS-CoV-2
|PLoS Pathogens|2021|62
Approaches for timeline reductions in pathogenesis studies using genetically modified mice
|Microbiology Spectrum|2023|9